CS logo
small CS logo
IRCCS Ca' Granda Ospedale Maggiore Policlinico; Centro Emofilia e Trombosi "Angelo Bianchi e Bonomi"

Milano, Lombardia, Italy
Medical center in Milan
Via Pace, 9, 20122 Milano MI

About IRCCS Ca' Granda Ospedale Maggiore Policlinico; Centro Emofilia e Trombosi "Angelo Bianchi e Bonomi"


"Il Centro Emofilia e Trombosi Angelo Bianchi Bonomi, diretto dalla Professoressa Flora Peyvandi, fornisce un ampio ventaglio di prestazioni, per fare diagnosi e per intervenire direttamente su emofilia e malattie della coagulazione, emorragiche e trombotiche. Si rivolge a persone di tutte le età: neonati, bambini, adulti e anziani. Il Centro assiste ogni anno in regime ambulatoriale, di day hospital e ricovero ospedaliero, più di 3000 pazienti affetti da malattie emorragiche e trombotiche. Il Centro si distingue per un'attività di ricerca applicata alla clinica."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
8
Total Rows: 1

Clinical Trials at IRCCS Ca' Granda Ospedale Maggiore Policlinico; Centro Emofilia e Trombosi "Angelo Bianchi e Bonomi"


During the past decade, IRCCS Ca' Granda Ospedale Maggiore Policlinico; Centro Emofilia e Trombosi "Angelo Bianchi e Bonomi" conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22221100001111110000111111001100Started TrialsCompleted Trails201520162017201820192020202120220123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Prospective Study to Collect High-Quality Documentation of Bleeds, Health-Related Quality of Life (HRQoL), and Safety Outcomes in Patients With Hemophilia A Treated With Standard-of-Care Treatment
2015-05-26
2017-03-31
Completed
221
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors
2015-11-18
2020-12-01
Completed
113
A Study of Emicizumab Administered Subcutaneously (SC) in Pediatric Participants With Hemophilia A and Factor VIII (FVIII) Inhibitors
2016-07-22
2020-11-11
Completed
88
A Clinical Trial to Evaluate Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without Inhibitors
2016-09-27
2022-05-12
Completed
152
A Study to Evaluate the Safety and Tolerability of Prophylactic Emicizumab in Hemophilia A Patients With Inhibitors
2017-09-05
2020-11-19
Completed
195
An Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Participants With Haemophilia A Without Inhibitors Receiving Standard of Care Treatment
2020-02-24
2022-04-28
Completed
107
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Emicizumab in Participants From Birth to 12 Months of Age With Hemophilia A Without Inhibitors
2021-02-04
2029-12-16
Active, not recruiting
55
A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis
2022-06-20
2026-10-17
Recruiting
120

Rows per page:

1–8 of 8

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "IRCCS Ca' Granda Ospedale Maggiore Policlinico; Centro Emofilia e Trombosi "Angelo Bianchi e Bonomi"" #1 collaborator was "Chugai Pharmaceutical" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 8Hoffmann-La Roche: 8

Created with Highcharts 11.1.0Top CollaboratorsChugai Pharmaceutical: 3Chugai Pharmaceutical: 3

Clinical Trials Conditions at IRCCS Ca' Granda Ospedale Maggiore Policlinico; Centro Emofilia e Trombosi "Angelo Bianchi e Bonomi"


According to Clinical.Site data, the most researched conditions in "IRCCS Ca' Granda Ospedale Maggiore Policlinico; Centro Emofilia e Trombosi "Angelo Bianchi e Bonomi"" are "Hemophilia A" (5 trials), "Severe Hemophilia A" (2 trials), "Haemophilia A" (1 trials), "Moderate Hemophilia A" (1 trials) and "Moderate Hereditary Factor VIII Deficiency Disease Without Inhibitor" (1 trials). Many other conditions were trialed in "IRCCS Ca' Granda Ospedale Maggiore Policlinico; Centro Emofilia e Trombosi "Angelo Bianchi e Bonomi"" in a lesser frequency.

Clinical Trials Intervention Types at IRCCS Ca' Granda Ospedale Maggiore Policlinico; Centro Emofilia e Trombosi "Angelo Bianchi e Bonomi"


Most popular intervention types in "IRCCS Ca' Granda Ospedale Maggiore Policlinico; Centro Emofilia e Trombosi "Angelo Bianchi e Bonomi"" are "Drug" (8 trials). Other intervention types were less common.
The name of intervention was led by "Emicizumab" (6 trials), "Bypassing Agents" (1 trials), "FVIII Replacement" (1 trials), "Factor VIII (FVIII)" (1 trials) and "Standard of Care for Haemophilia A" (1 trials). Other intervention names were less common.

Clinical Trials Genders at IRCCS Ca' Granda Ospedale Maggiore Policlinico; Centro Emofilia e Trombosi "Angelo Bianchi e Bonomi"


The vast majority of trials in "IRCCS Ca' Granda Ospedale Maggiore Policlinico; Centro Emofilia e Trombosi "Angelo Bianchi e Bonomi"" are 8 trials for "All" genders.

Clinical Trials Status at IRCCS Ca' Granda Ospedale Maggiore Policlinico; Centro Emofilia e Trombosi "Angelo Bianchi e Bonomi"


Currently, there are NaN active trials in "IRCCS Ca' Granda Ospedale Maggiore Policlinico; Centro Emofilia e Trombosi "Angelo Bianchi e Bonomi"". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in IRCCS Ca' Granda Ospedale Maggiore Policlinico; Centro Emofilia e Trombosi "Angelo Bianchi e Bonomi", undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in IRCCS Ca' Granda Ospedale Maggiore Policlinico; Centro Emofilia e Trombosi "Angelo Bianchi e Bonomi", 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 5Phase 3: 5Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 6Completed: 6Active, not recruiting: 1Active, not recruiting: 1Recruiting: 1Recruiting: 1